BSX|Boston Scientific Corp|Preço:76.270|Var. %:-1.38

Mais detalhes de Boston Scientific Corp Empresa

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Informações de Boston Scientific Corp



Código da empresaBSX

Nome da EmpresaBoston Scientific Corp

Data de listagemMay 19, 1992

CEOMahoney (Michael F)

Número de funcionários53000

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 19

Endereço300 Boston Scientific Way

CidadeMARLBOROUGH

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal01752-1234

Telefone15086834000

Sitehttps://www.bostonscientific.com/en-US/Home.html

Código da empresaBSX

Data de listagemMay 19, 1992

CEOMahoney (Michael F)

Executivos da empresa Boston Scientific Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-58824.00%

Mr. John E. Sununu

Independent Director

54.72K

+2081.00%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+2081.00%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+562.00%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+2084.00%

Ms. Ellen M. Zane

Independent Director

24.13K

-12891.00%

Mr. David C. Habiger

Independent Director

5.63K

+2081.00%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-2901.00%

Ms. Miriam O' Sullivan

Chief Human Resources Officer, Senior Vice President

--

Mr. Joseph M. Fitzgerald

Executive Vice President, Group President - Cardiology

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-58824.00%

Mr. John E. Sununu

Independent Director

54.72K

+2081.00%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+2081.00%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+562.00%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+2084.00%

Ms. Ellen M. Zane

Independent Director

24.13K

-12891.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Endoscopy

747.00M

14.75%

Peripheral Interventions

702.00M

13.86%

Urology

682.00M

13.46%

Electrophysiology

607.00M

11.98%

Watchman

470.00M

9.28%

Outro

1.86B

36.66%

Por RegiãoUSD

Nome

Receita

Proporção

United States

3.29B

65.03%

Asia Pacific

802.00M

15.83%

EMEA (Europe, Middle East and Africa)

793.00M

15.66%

Latin America and Canada

175.00M

3.46%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Endoscopy

747.00M

14.75%

Peripheral Interventions

702.00M

13.86%

Urology

682.00M

13.46%

Electrophysiology

607.00M

11.98%

Watchman

470.00M

9.28%

Outro

1.86B

36.66%

Distribuição de ações

Atualizado em: dom, 1 de fev

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

9.37%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

Outro

72.54%

Investidores

Proporção

The Vanguard Group, Inc.

9.37%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

Outro

72.54%

Tipos de investidores

Investidores

Proporção

Investment Advisor

51.52%

Investment Advisor/Hedge Fund

29.10%

Hedge Fund

4.91%

Pension Fund

2.90%

Research Firm

2.71%

Bank and Trust

1.98%

Sovereign Wealth Fund

1.58%

Family Office

0.29%

Private Equity

0.19%

Outro

4.83%

Participação acionária institucional



Atualizado em: seg, 8 de dez

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q4

2858

1.40B

94.34%

-402.85K

2025Q3

2905

1.40B

94.56%

+9.92M

2025Q2

2818

1.39B

94.08%

+7.87M

2025Q1

2724

1.38B

93.98%

-8.23M

2024Q4

2559

1.38B

93.68%

+12.79M

2024Q3

2401

1.36B

94.13%

-3.01M

2024Q2

2325

1.37B

94.20%

+2.64M

2024Q1

2212

1.37B

95.15%

-32.63M

2023Q4

2153

1.38B

96.34%

-8.17M

2023Q3

2083

1.39B

95.41%

+17.41M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

137.57M

9.28%

+1.09M

+0.80%

Sep 30, 2025

Fidelity Management & Research Company LLC

90.62M

6.11%

-8.85M

-8.90%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

79.60M

5.37%

+1.41M

+1.81%

Sep 30, 2025

State Street Investment Management (US)

64.93M

4.38%

-266.30K

-0.41%

Sep 30, 2025

PRIMECAP Management Company

33.10M

2.23%

-1.56M

-4.50%

Sep 30, 2025

Geode Capital Management, L.L.C.

32.69M

2.21%

+265.55K

+0.82%

Sep 30, 2025

Capital World Investors

26.65M

1.8%

-1.88M

-6.58%

Sep 30, 2025

Managed Account Advisors LLC

23.16M

1.56%

+1.11M

+5.03%

Sep 30, 2025

The Bollard Group, LLC

19.73M

1.33%

-345.87K

-1.72%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

19.46M

1.31%

-275.11K

-1.39%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: seg, 1 de dez

Nome

Proporção

iShares U.S. Medical Devices ETF

12.15%

Goldman Sachs Future Health Care Equity ETF

8.33%

Invesco Dorsey Wright Healthcare Momentum ETF

3.87%

Tema Heart & Health ETF

3.66%

First Trust Bloomberg R&D Leaders ETF

3.14%

Parnassus Core Select ETF

3.1%

WisdomTree US AI Enhanced Value Fund

3.1%

Health Care Select Sector SPDR Fund

3.06%

Global X Aging Population ETF

2.99%

Proshares Ultra Health Care

2.95%

Ver Mais

iShares U.S. Medical Devices ETF

Proporção12.15%

Goldman Sachs Future Health Care Equity ETF

Proporção8.33%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporção3.87%

Tema Heart & Health ETF

Proporção3.66%

First Trust Bloomberg R&D Leaders ETF

Proporção3.14%

Parnassus Core Select ETF

Proporção3.1%

WisdomTree US AI Enhanced Value Fund

Proporção3.1%

Health Care Select Sector SPDR Fund

Proporção3.06%

Global X Aging Population ETF

Proporção2.99%

Proshares Ultra Health Care

Proporção2.95%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados